- stock
Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- Reagent
- custom synthesis
Supplier Region
- Hyderabad(43)
- Ahmedabad(20)
- Maharashtra(36)
- Mallapur(1)
- New Delhi(6)
- Gujarat(45)
- Mumbai(95)
- Karnataka(7)
- Andhra Pradesh(7)
- Beijing(3)
- Delhi(16)
- Tamil Nadu(6)
- Pune(8)
- Vadodara(13)
- Bangalore(1)
- Telangana(5)
- Madhya Pradesh(3)
- Uttar Pradesh(6)
- Kolkata(5)
- Haryana(5)
- Nagpur(2)
- Kerela(1)
- West Bengal(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- PURE
- Other
- NLT95%
- NLT 98%
- NLT 95%
- NLT 90%
- N/A
- more than 95%
- more than 90%
- min 99.0%
- Min 99. 00%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- High Purity
- Greater than 99%
- good
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.95%
- 99.94%
- 99.91%
- 99.90%
- 99.9%
- 99.9 %
- 99.86%
- 99.85%
- 99.73%
- 99.50%
- 99.5%+
- 99.5%
- 99.42%
- 99.29%
- 99.0% min
- 99%+
- 99% min
- 99%
- >99%
- > 99%
- 99 % +
- 99 %
- 99
- 98+
- 98.60%
- 98.5 %
- 98.12%
- 98.0 %
- 98% Min
- >98%
- 98%
- 98 %
- 97-99%
- 97-99 %
- 97.57%
- 97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96%
- 96 PURITY
- 95-99%
- 95-98%
- >95%
- 95%
- 95
- >92%
- 90-95%
- 90%
- >90%
- 85%
- 80-90%
- 50%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- gms
- 0MG TO GRAM
- 25MG
- 500mg
- 1gm
- 1g
- 5g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100mg
- 250mg
- 1000mg
- 10g
- 25g
- 100g
- 250g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 63kg
- 100kg
- 102kg
- 123kg
- 124kg
- 125kg
- 126kg
- 127kg
- 128kg
- 129kg
- 167kg
- 250kg
- 500kg
- 1MT
- 5>
- 5gms
- 25gms
- 50kg drum
- 95NLT %
- 100gms
- 200Kg drum
- 500gms
-
3,5-Pyridinedicarboxylic acid, 4-(2-chlorophenyl)-1,4-dihydro-2-[[2-[[2-[[(2-hydroxyethyl)amino]carbonyl]benzoyl]amino]ethoxy]methyl]-6-methyl-, 3-ethyl 5-methyl ester
3079028-35-3
-
Ethyl bromoacetate
105-36-2
-
Trinexapac-ethyl
95266-40-3
-
4-Methylumbelliferone
90-33-5
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
Ethyl trifluoroacetate
383-63-1
-
3''-Acetyl-2''-hydroxy-4-(4-phenylbutoxy)benzanilide
136450-06-1
-
Ethyl 2-methylthiazole-5-carboxylate
79836-78-5
-
4-Hydroxy-but-2-enoic acid
24587-49-3
-
2-hydroxy-5-(methylthio)benzaldehyde
67868-84-2
Ethyl bromoacetate 105-36-2
Trinexapac-ethyl 95266-40-3
7-Hydroxy-4-methylcoumarin 90-33-5
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
Ethyl 2-methylthiazole-5-carboxylate 79836-78-5
(2E)-4-Hydroxy-2-butenoic acid 24587-49-3
Methyl ethyl ketone 78-93-3
L-Alanine ethyl ester hydrochloride 1115-59-9
(3R,4R)-1-Benzyl-4-hydroxy-3-pyrrolidinemethanol 253129-03-2